Citations

Clear

1575 citation(s) found for "Im, Gene".

The VITAL study: A randomized, double-blind, placebo-controlled, global, phase III study of NEOD001 in patients with AL amyloidosis and cardiac dysfunction.
Liedtke, Michaela , Landau, Heather , Comenzo, Ray, Weiss, Brendan M. , Zonder, Jeffrey A. , Walling, Jackie , Kinney, Gene G. , Koller, Marty, Merlini, Giampaolo , Seldin, David C. , Gertz, Morie A.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 8614-8614

10.1200/jco.2015.33.15_suppl.8614 Get It

Association of rs613872 and Trinucleotide Repeat Expansion in the TCF4 Gene of German Patients With Fuchs Endothelial Corneal Dystrophy
Okumura, Naoki , Hayashi, Ryousuke, Nakano, Masakazu , Tashiro, Kei, Yoshii, Kengo, Aleff, Ross A., Butz, Malinda L., Highsmith, Edward W., Wieben, Eric D. , Fautsch, Michael P. , Baratz, Keith H. , Komori, Yuya, Ueda, Emi , Nakahara, Makiko , Weller, Julia M. , Tourtas, Theofilos , Schlötzer‐Schrehardt, Ursula , Kruse, Friedrich E., Koizumi, Noriko , Aleff, Ross, Butz, Malinda

Mayo Clinic

Cornea | April 9, 2019 | Volume: 38 | Issue: 7 | Pages: 799-805

10.1097/ico.0000000000001952 | PMID 30973406 Get It

Purpose: To investigate single nucleotide polymorphisms (SNPs) and trinucleotide repeat (TNR) expansion in the transcription factor 4 (TCF4) gene in a large cohort of German patients with Fuchs endothelial corneal dystrophy (FECD). Methods: Genomic DNA was obtained from 398 patients with FECD and from 58 non-FECD controls. Thirty-seven previously reported SNPs were evaluated by genotyping. The 398 FECD samples were analyzed for TNR expansions by short tandem repeat assays and Southern blotting. The possible associations between the TNR length and clinical parameters (age, sex, visual acuity, and central corneal thickness) were analyzed in 132 patients. Results: The SNPs in COL8A2, TCF8, LOXHD1, and AGBL1 showed no heterogeneity in 36 cases, although SLCA411 showed 3 nonsense mutations. SNPs were detected for TCF4 (rs613872, rs2123392, rs17089887, rs1452787, and rs1348047), but only rs613872 showed a significant association with FECD (P = 9.93 × 10−12). Overall, 315/398 (79%) patients harbored TNR lengths >50, whereas no non-FECD controls harbored TNR lengths >50. The TCF4 SNP rs613872 genotype was TT: 39 (67%), TG: 18 (31%), and GG: 1 (2%) in non-FECD controls; TT: 39 (47%), TG: 38 (46%), and GG: 6 (7%) in FECD cases harboring TNR <50; and TT: 23 (8%), TG: 224 (79%), and GG: 38 (13%) in FECD cases harboring TNR >50 (P = 2.93 × 10−25). No significant association was detected between the TNR length and clinical parameters. Conclusions: Our large German cohort demonstrated a significant association between the risk allele G in rs613872 and FECD, irrespective of TNR expansion, although this risk allele was more frequent in FECD cases with TNR expansion than without.
White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities
Alber, Jessica , Alladi, Suvarna , Barton, David A., Bell, Joanne M., Berman, Sara E., Biessels, Geert Jan , Bos, Isabelle , Bowman, Gene L. , Brai, Emanuele , Callahan, Brandy L. , Corriveau, Roderick A. , Fossati, Silvia , Gottesman, Rebecca F. , Gustafson, Deborah , Hachinski, Vladimir , Hayden, Kathleen M. , Helman, Alex M., Hughes, Timothy M. , Isaacs, Jeremy D. , Jefferson, Angela L. , Kern, Silke , Kwon, Jay C., Lee, Athene , Lockhart, Samuel N. , Murray, Anne M. , Osborn, Katie E. , Price, Brittani R. , Rhodius‐Meester, Hanneke , Rondeau, Jacqueline A., Rosen, Allyson , Scholtzova, Henrieta , Shaaban, C. Elizabeth , Silva, Nárlon Cássio Boa Sorte , Snyder, Heather M. , Swardfager, Walter , Troen, Aron M. , Vemuri, Prashanthi , Wallin, Anders , Wellington, Cheryl L. , Xie, Sharon X. , Hainsworth, Atticus H. , Vemuri, Prashanthi , Gottesman, Rebecca F , Hainsworth, Atticus H , Bae, Hee‐Joon , Beckett, Laurel , Biessels, Geert Jan , Black, Sandra E. , Brickman, Adam M. , Johnson, Sterling C. , Kapasi, Alifiya , Kukolja, Juraj , Power, Melinda C. , Rosene, Douglas L , Schneider, Julie A. , Veluw, Susanne J. van , Wilcock, Donna M.

Mayo Clinic

Alzheimer's & Dementia: Translational Research & Clinical Interventions | April 8, 2019 | Volume: 5 | Issue: 1 | Pages: 107-117

10.1016/j.trci.2019.02.001 | PMID 31011621 Get It

Abstract White matter hyperintensities (WMHs) are frequently seen on brain magnetic resonance imaging scans of older people. Usually interpreted clinically as a surrogate for cerebral small vessel disease, WMHs are associated with increased likelihood of cognitive impairment and dementia (including Alzheimer's disease [AD]). WMHs are also seen in cognitively healthy people. In this collaboration of academic, clinical, and pharmaceutical industry perspectives, we identify outstanding questions about WMHs and their relation to cognition, dementia, and AD. What molecular and cellular changes underlie WMHs? What are the neuropathological correlates of WMHs? To what extent are demyelination and inflammation present? Is it helpful to subdivide into periventricular and subcortical WMHs? What do WMHs signify in people diagnosed with AD? What are the risk factors for developing WMHs? What preventive and therapeutic strategies target WMHs? Answering these questions will improve prevention and treatment of WMHs and dementia.
Single-Cell RNA-Sequencing and Optical Electrophysiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Discordance Between Cardiac Subtype-Associated Gene Expression Patterns and Electrophysiological Phenotypes
Biendarra‐Tiegs, Sherri M., Ye, Dan , Brandt, Emma B. , Ackerman, Michael J. , Li, Xing , Nelson, Timothy J.

Mayo Clinic

Stem Cells and Development | March 20, 2019 | Volume: 28 | Issue: 10 | Pages: 659-673

10.1089/scd.2019.0030 | PMID 30892143 Get It

The ability to accurately phenotype cells differentiated from human induced pluripotent stem cells (hiPSCs) is essential for their application in modeling developmental and disease processes, yet also poses a particular challenge without the context of anatomical location. Our specific objective was to determine if single-cell gene expression was sufficient to predict the electrophysiology of iPSC-derived cardiac lineages, to evaluate the concordance between molecular and functional surrogate markers. To this end, we used the genetically encoded voltage indicator ArcLight to profile hundreds of hiPSC-derived cardiomyocytes (hiPSC-CMs), thus identifying patterns of electrophysiological maturation and increased prevalence of cells with atrial-like action potentials (APs) between days 11 and 42 of differentiation. To profile expression patterns of cardiomyocyte subtype-associated genes, single-cell RNA-seq was performed at days 12 and 40 after the populations were fully characterized with the high-throughput ArcLight platform. Although we could detect global gene expression changes supporting progressive differentiation, individual cellular expression patterns alone were not able to delineate the individual cardiomyocytes into atrial, ventricular, or nodal subtypes as functionally documented by electrophysiology measurements. Furthermore, our efforts to understand the distinct electrophysiological properties associated with day 12 versus day 40 hiPSC-CMs revealed that ion channel regulators SLMAP , FGF12 , and FHL1 were the most significantly increased genes at day 40, categorized by electrophysiology-related gene functions. Notably, FHL1 knockdown during differentiation was sufficient to significantly modulate APs toward ventricular-like electrophysiology. Thus, our results establish the inability of subtype-associated gene expression patterns to specifically categorize hiPSC-derived cells according to their functional electrophysiology, and yet, altered FHL1 expression is able to redirect electrophysiological maturation of these developing cells. Therefore, noncanonical gene expression patterns of cardiac maturation may be sufficient to direct functional maturation of cardiomyocytes, with canonical gene expression patterns being insufficient to temporally define cardiac subtypes of in vitro differentiation.
Multi-Level Model to Predict Antibody Response to Influenza Vaccine Using Gene Expression Interaction Network Feature Selection
Parvandeh, Saeid , Poland, G. A., Kennedy, Richard B. , McKinney, Brett A. , Poland, Greg A, Kennedy, Richard

Mayo Clinic

Microorganisms | March 15, 2019 | Volume: 7 | Issue: 3 | Pages: 79

10.3390/microorganisms7030079 | PMID 30875727 Get It

Vaccination is an effective prevention of influenza infection. However, certain individuals develop a lower antibody response after vaccination, which may lead to susceptibility to subsequent infection. An important challenge in human health is to find baseline gene signatures to help identify individuals who are at higher risk for infection despite influenza vaccination. We developed a multi-level machine learning strategy to build a predictive model of vaccine response using pre−vaccination antibody titers and network interactions between pre−vaccination gene expression levels. The first-level baseline−antibody model explains a significant amount of variation in post-vaccination response, especially for subjects with large pre−existing antibody titers. In the second level, we clustered individuals based on pre−vaccination antibody titers to focus gene−based modeling on individuals with lower baseline HAI where additional response variation may be predicted by baseline gene expression levels. In the third level, we used a gene−association interaction network (GAIN) feature selection algorithm to find the best pairs of genes that interact to influence antibody response within each baseline titer cluster. We used ratios of the top interacting genes as predictors to stabilize machine learning model generalizability. We trained and tested the multi-level approach on data with young and older individuals immunized against influenza vaccine in multiple cohorts. Our results indicate that the GAIN feature selection approach improves model generalizability and identifies genes enriched for immunologically relevant pathways, including B Cell Receptor signaling and antigen processing. Using a multi-level approach, starting with a baseline HAI model and stratifying on baseline HAI, allows for more targeted gene−based modeling. We provide an interactive tool that may be extended to other vaccine studies.
Comment: Longevity gene KLOTHO may play a role in Alzheimer disease
Harten, Argonde C. van , van Harten, Argonde C

Mayo Clinic

Neurology | March 14, 2019 | Volume: 92 | Issue: 16 | Pages: 751-751

10.1212/wnl.0000000000007302 | PMID 30867268 Get It

Hepatotoxicity and Toxicology of In Vivo Lentiviral Vector Administration in Healthy and Liver-Injury Mouse Models
Kaiser, Robert A. , Nicolas, Clara T., Allen, Kari L. , Chilton, Jennifer A., Du, Zeji , Lillegard, Joseph B. , Kaiser, Robert Allen, Nicolas, Clara Teresa, Allen, Kari Lynn, Hickey, Raymond Daniel, Lillegard, Joseph Benjamin, Hickey, Raymond

Mayo Clinic

Human Gene Therapy Clinical Development | March 12, 2019 | Volume: 30 | Issue: 2 | Pages: 57-66

10.1089/humc.2018.249 | PMID 30860398 Get It

Variation in TRMT11 gene as a prognostic marker in advanced-stage castrate-resistant prostate cancer (CRPC) patients.
Zhang, Ben Yiming, Riska, Shaun M., Ribeiro, Ricardo , Medeiros, Rui , Monteiro, Cátia, Nogueira, Augusto, Maurício, Joaquina, Fraga, Avelino , Calais-Da-Silva, Fernando, Costello, Brian A. , Dronca, Roxana , Pitot, Henry C., Moynihan, Timothy J. , Quevedo, Fernando , Mahoney, Douglas W. , Cerhan, James R. , Kohli, Manish

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e16114-e16114

10.1200/jco.2015.33.15_suppl.e16114 Get It

Associations of HER2-specific immunity with survival during treatment with trastuzumab and chemotherapy in breast cancer.
Knutson, Keith L. , Clynes, Raphael , Yeramian, Patrick, Kemp, Kathleen P., Shreeder, Barath , Tenner, Kathleen , Erskine, Courtney L. , Norton, Nadine , Northfelt, Donald W. , Tan, Winston , Pegram, Mark D. , Calfa, Carmen , Perez, Edith A. , Knutson, Keith L. , Ballman, Karla V. , Mittendorf, EA , Norton, Nadine

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 587-587

10.1200/jco.2015.33.15_suppl.587 Get It

Comparison of HER2 gene amplification (AMP) in primary esophageal and gastroesophageal junction adenocarcinomas (EAC) and their metastatic regional lymph nodes (MLNs).
Yoon, Harry H. , Sukov, William R. , Sattler, Christopher A., Wiktor, Anne E., Diasio, Robert B. , Wu, Tsung‐Teh, Jenkins, Robert B. , Shi, Qian , Sinicrope, Frank A.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 4059-4059

10.1200/jco.2015.33.15_suppl.4059 Get It